Article metrics

Download PDFPDF

Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe

 

Online download statistics by month:

Online download statistics by month: December 2020 to October 2021

AbstractFullPdf
Dec 202013313330
Jan 202129829735
Feb 2021797826
Mar 2021484715
Apr 2021191911
May 2021202015
Jun 202117178
Jul 202120209
Aug 2021161612
Sep 2021171712
Oct 2021888
Total675672181